Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group
Authors:
- Stephen D. WilliamsSWStephen D. Williams
- James KaudererJKJames Kauderer
- Alexander F. BurnettABAlexander F. Burnett
- Samuel S. LentzSLSamuel S. Lentz
- Carol AghajanianCACarol Aghajanian
- Deborah K. ArmstrongDADeborah K. Armstrong
- 1 December 2004
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 95 (3) , 496-499
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Outcome and Reproductive Function After Chemotherapy for Ovarian DysgerminomaJournal of Clinical Oncology, 1999
- Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.Journal of Clinical Oncology, 1997
- Cisplatin-Based Chemotherapy in the Management of Germ Cell Tumors of the Ovary: The Institut Gustave Roussy ExperienceGynecologic Oncology, 1997
- Cisplatin-Based Chemotherapy in Dysgerminoma of the Ovary: Thirteen-Year Experience at the Institut Gustave RoussyGynecologic Oncology, 1995
- Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial.Journal of Clinical Oncology, 1995
- Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.Journal of Clinical Oncology, 1994
- Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.Journal of Clinical Oncology, 1991
- Long-term effects of radiation therapy on patients with ovarian dysgerminomaCancer, 1991
- Cisplatin, Vinblastine, and Bleomycin in Advanced and Recurrent Ovarian Germ-Cell TumorsAnnals of Internal Medicine, 1989
- Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience.Journal of Clinical Oncology, 1987